Lena U Rosenberg

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study
    Lena U Rosenberg
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, S 171 77 Stockholm, Sweden
    Breast Cancer Res 8:R11. 2006
  2. ncbi Risk factors for hormone receptor-defined breast cancer in postmenopausal women
    Lena U Rosenberg
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P O Box 281, SE 171 77 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 15:2482-8. 2006
  3. ncbi Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
    Lena U Rosenberg
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 10:R78. 2008
  4. ncbi The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer
    Chantal C Orgéas
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels vag 12a, Stockholm, SE 17177, Sweden
    Breast Cancer Res 10:R107. 2008
  5. ncbi Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
    Kristjana Einarsdóttir
    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Nobels vag 12a, 171 77 Solna, Sweden
    Breast Cancer Res 8:R67. 2006

Detail Information

Publications5

  1. ncbi Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study
    Lena U Rosenberg
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, S 171 77 Stockholm, Sweden
    Breast Cancer Res 8:R11. 2006
    ..There are also indications of differences in aetiology. We therefore evaluated the risk of the three most common histological subtypes in relation to menopausal hormone therapy and other breast cancer risk factors...
  2. ncbi Risk factors for hormone receptor-defined breast cancer in postmenopausal women
    Lena U Rosenberg
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, P O Box 281, SE 171 77 Stockholm, Sweden
    Cancer Epidemiol Biomarkers Prev 15:2482-8. 2006
    ....
  3. ncbi Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study
    Lena U Rosenberg
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
    Breast Cancer Res 10:R78. 2008
    ..We assessed these associations in a Swedish cohort of postmenopausal breast cancer patients holding information on mammographic examinations, menopausal hormone therapy use, other breast cancer risk factors, and cancer treatment...
  4. ncbi The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer
    Chantal C Orgéas
    Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Nobels vag 12a, Stockholm, SE 17177, Sweden
    Breast Cancer Res 10:R107. 2008
    ..Our study investigated the effects of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer...
  5. ncbi Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study
    Kristjana Einarsdóttir
    Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Nobels vag 12a, 171 77 Solna, Sweden
    Breast Cancer Res 8:R67. 2006
    ..However, whether common variation in these genes has a role in the development of breast cancer or breast cancer survival in humans is still not clear...